Shenzhen Kangtai Biological Products Co., Ltd.

SZSE:300601.SZ

28.75 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Revenue 816.136739.511448.8951,002.546733.896982.186748.383592.338737.22956.418871.4251,274.8451,325.046775.211276.994840.836550.398692.741177.202549.093586.582466.078341.578516.943436.258660.392403.309366.794325.072323.317145.993211.97134.77758.845146.35120.022111.321
Cost of Revenue 139.008164.12471.962220.788114.429123.947105.437167.08989.48121.026122.353621.325201.38123.90539.818125.58838.74547.1114.86350.58442.77945.69724.61439.53841.57762.2836.01846.20637.23133.84719.05134.92927.86623.45732.04148.66841.176
Gross Profit 677.129575.387376.932781.758619.466858.239642.946425.249647.74835.393749.073653.521,123.665651.306237.175715.248511.653645.631162.339498.51543.803420.381316.964477.405394.682598.111367.292320.588287.841289.47126.942177.04106.91135.388114.30871.35470.145
Gross Profit Ratio 0.830.7780.840.780.8440.8740.8590.7180.8790.8730.860.5130.8480.840.8560.8510.930.9320.9160.9080.9270.9020.9280.9240.9050.9060.9110.8740.8850.8950.870.8350.7930.6010.7810.5950.63
Reseach & Development Expenses 91.58195.321107.61129.471113.695160.33984.467220.974240.815244.46595.603131.99797.05258.93766.278124.82757.34950.10934.77672.59554.24644.54826.87193.27236.02963.42615.10633.57712.51638.644039.533016.12048.2630
General & Administrative Expenses 198.713-27.60873.516-108.47142.882-23.18651.651-128.716139.014-9.72957.629-96.238137.493-26.02250.275-85.74841.082-20.44436.145-78.5438.716-23.5838.217-47.3332.081-24.98439.205-81.9737.539-8.51926.885-48.03824.012-11.2222.026-54.24121.569
Selling & Marketing Expenses 295.024237.14159.757385.944249.081337.233259.204199.696279.626318.304288.73490.265142.467224.264121.243303.5230.068260.63884.201233.911244.682179.272126.708255.287219.834332.851197.359205.172164.422175.8769.955124.99158.36617.08319.29526.56729.813
SG&A 493.737338.174245.91449.947391.963314.047310.85570.98418.639308.575346.364-5.973279.96198.242171.518217.752271.15240.194120.346155.371283.398155.693164.926207.957251.915307.867236.564123.202201.961167.35196.8476.95482.3785.86341.321-27.67451.383
Other Expenses -141.053-67.947-0.346-74.752-1.151-0.067-15.393136.743-89.79157.835-30.379-1.555-0.625-10.970.153.837-1.201-3.607-1.9892.3410.1063.186-0.001-3.1473.5423.5113.922-30.97518.8631.4656.472.0841.3569.4790.6991.2010.025
Operating Expenses 444.264501.441353.865654.17426.374465.952379.928428.697569.663610.876411.588222.749313.69298.865236.633462.439325.388348.468154.036327.457337.67244.152189.801401.487288.673393.606237.227226.929203.619228.94397.681156.24282.84641.67141.80258.78251.801
Operating Income 198.43873.94623.067127.588202.393322.009244.347-470.1664.347235.472327.201255.816808.677358.13829.615265.802205.201299.225.148162.135203.35174.719117.61352.28102.46200.846125.67486.96183.55244.85426.79510.60220.367-18.00272.71110.30817.071
Operating Income Ratio 0.2430.10.0510.1270.2760.3280.327-0.7940.0870.2460.3750.2010.610.4620.1070.3160.3730.4320.0290.2950.3470.3750.3440.1010.2350.3040.3120.2370.2570.1390.1840.050.151-0.3060.4970.0860.153
Total Other Income Expenses Net -0.667-2.41542.09247.73-1.151-0.067-2.529-11.36-5.665-472.88-5.201-1.555-1.923-5.27429.22316.8317.735-1.549-5.145-6.577-2.6761.676-9.552-26.785-0.007-0.148-0.468-36.4518.152-15.3633.976-8.213-2.37-2.3140.791-1.349-1.273
Income Before Tax 197.77171.53165.159175.317201.242321.942241.818-481.5258.682-237.409322254.26808.053347.16729.765269.639204295.6133.158164.475203.456177.905117.61249.133106.002204.357129.59657.21102.37445.16433.23712.58621.694-8.59773.29711.22317.071
Income Before Tax Ratio 0.2420.0970.1450.1750.2740.3280.323-0.8130.08-0.2480.370.1990.610.4480.1070.3210.3710.4270.0180.30.3470.3820.3440.0950.2430.3090.3210.1560.3150.140.2280.0590.161-0.1460.5010.0940.153
Income Tax Expense 12.047-39.79211.1311.06414.62316.97436.355-145.665-23.963-84.32348.41227.096108.39135.7684.61223.78530.47838.2270.73420.81530.78619.45117.891-10.35316.1727.8719.717-1.13316.562.7485.1060.7753.375-2.5411.157-0.2212.681
Net Income 185.759111.2754.066164.253186.619304.969205.463-335.85582.644-153.085273.588227.164699.661311.39925.153245.854173.521257.3872.424143.661172.67158.45499.72159.48789.832176.487109.87958.34385.81442.41628.1311.81118.319-6.05762.14111.44414.389
Net Income Ratio 0.2280.150.120.1640.2540.3110.275-0.5670.112-0.160.3140.1780.5280.4020.0910.2920.3150.3720.0140.2620.2940.340.2920.1150.2060.2670.2720.1590.2640.1310.1930.0560.136-0.1030.4250.0950.129
EPS 0.170.10.0480.150.170.270.18-0.30.12-0.220.40.211.030.460.0230.370.160.40.0020.230.170.250.10.0930.0880.290.110.0950.0880.0710.0290.0220.021-0.0110.0710.0210.017
EPS Diluted 0.170.10.0480.150.170.270.18-0.30.12-0.220.40.211.030.460.0230.370.160.40.0020.230.170.250.10.0930.0880.290.110.0950.0880.0710.0290.0220.021-0.0110.0710.0210.017
EBITDA 227.334152.447110.066197.215220.84419.563291.72113.64102.984264.54365.861452.175843.353408.37420.22251.186207.95311.718.154175.081208.921182.631130.10474.973113.336215.145133.19574.61385.06267.1331.21332.25439.6594.26472.6227.68919.672
EBITDA Ratio 0.2790.2060.2450.1970.3010.4270.390.0230.140.2770.420.3550.6360.5270.0730.2990.3780.450.0460.3190.3560.3920.3810.1450.260.3260.330.2030.2620.2080.2140.1520.2940.0720.4960.2310.177